MolNFT v1 · #115125 · protein
Structure of leishmania nucleoside diphostate kinase mutant DEL5-cterm
5CAB · Nucleoside diphosphate kinase: “Structure of leishmania nucleoside diphostate kinase mutant DEL5-cterm”. X-ray diffraction, 1 ligand (SO4), 5 pockets (best druggability 0.47). MolNFT v1 #115125 on GenesisL1: 3D structure, binding…
- PDB
- 5CAB
- Type
- protein
- Length
- 277 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Nucleoside diphosphate kinase
- EC
- 2.7.4.6
- UniProt
- Q9U1E1
- Ligands
- SO4
- Pockets
- 5 · best druggability 0.47
Structure
x-ray diffraction · 2 distinct chains · 49% helix, 17% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Nucleoside diphosphate kinase (EC 2.7.4.6) | protein | 139 | 49% helix, 17% strand | Q9U1E1 |
| B | Nucleoside diphosphate kinase (EC 2.7.4.6) | protein | 138 | 49% helix, 17% strand | Q9U1E1 |
Ligands and binding sites
- SO4 · Sulfate ion · ion · 2 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
5 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 191 | 0.47 | 0.75 | 24 | SO4 |
| 2 | 163 | 0.44 | 0.75 | 32 | SO4 |
| 3 | 80 | 0.37 | 0.77 | 17 | empty |
| 4 | 60 | 0.36 | 0.78 | 16 | empty |
| 5 | 52 | 0.33 | 0.78 | 17 | empty |
Interfaces
1 interface between chains.
- A–B · 631 Ų buried · 9 hydrogen bonds · protein-protein
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9U1E1
- Elsewhere: RCSB PDB 5CAB · PDBe 5CAB · UniProt Q9U1E1
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.